{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:43:38Z","timestamp":1773211418404,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.mehy.2011.02.027","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T04:37:41Z","timestamp":1299991061000},"page":"820-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica"],"prefix":"10.1016","volume":"76","author":[{"given":"Kai-Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Hsiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Piao","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.02.027_b0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11940-010-0071-z","article-title":"Neuromyelitis Optica","volume":"12","author":"Carroll","year":"2010","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2011.02.027_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","article-title":"Neuromyelitis optica","volume":"10","author":"Wingerchuk","year":"2008","journal-title":"Curr Treat Options Neurol"},{"issue":"11","key":"10.1016\/j.mehy.2011.02.027_b0015","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2011.02.027_b0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2010.05.030","article-title":"The rescue effect of plasma exchange for neuromyelitis optica","volume":"18","author":"Wang","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2011.02.027_b0025","first-page":"75","article-title":"Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?","volume":"15","author":"Bradl","year":"2008","journal-title":"Int MS J"},{"key":"10.1016\/j.mehy.2011.02.027_b0030","first-page":"117","article-title":"Role of interferons in demyelinating diseases","volume":"49","author":"Arnason","year":"1997","journal-title":"Ref J Neural Transm Suppl"},{"issue":"8","key":"10.1016\/j.mehy.2011.02.027_b0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers","volume":"67","author":"Palace","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2011.02.027_b0040","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.mehy.2011.02.027_b0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/1352458510380416","article-title":"Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population","volume":"16","author":"Vaknin-Dembinsky","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.mehy.2011.02.027_b0050","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/brain\/awn077","article-title":"Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity","volume":"131","author":"Krumbholz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2011.02.027_b0055","article-title":"Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica","author":"Kim","year":"2010","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.mehy.2011.02.027_b0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-003-0979-2","article-title":"A case of relapsing neuromyelitis optica treated with glatiramer acetate","volume":"250","author":"Bergamaschi","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2011.02.027_b0065","first-page":"12","article-title":"Relapsing neuromyelitis optica responsive to glatiramer acetate treatment","volume":"14","author":"Gartzena","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.mehy.2011.02.027_b0070","first-page":"126","article-title":"Glatiramer acetate treatment in Devic\u2019s neuromyelitis optica","author":"Bergamaschi","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mehy.2011.02.027_b0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1527-3458.2007.00010.x","article-title":"CNS Drug Rev","volume":"13","author":"Ruggieri","year":"2007","journal-title":"CNS Drug Rev"},{"issue":"1","key":"10.1016\/j.mehy.2011.02.027_b0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/08923970802379819","article-title":"The role of neurotrophic factors in the pathology and treatment of multiple sclerosis","volume":"31","author":"Mirowska-Guzel","year":"2009","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"11","key":"10.1016\/j.mehy.2011.02.027_b0085","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00702-009-0272-3","article-title":"Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate","volume":"116","author":"Arnon","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.mehy.2011.02.027_b0090","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mehy.2011.02.027_b0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2006.07.043","article-title":"Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study","volume":"406","author":"Blanco","year":"2006","journal-title":"Neurosci Lett"},{"issue":"52","key":"10.1016\/j.mehy.2011.02.027_b0100","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","article-title":"The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice","volume":"102","author":"Aharoni","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.mehy.2011.02.027_b0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1352458506070146","article-title":"Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins","volume":"13","author":"Sarchielli","year":"2007","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.mehy.2011.02.027_b0110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.mehy.2007.04.014","volume":"69","author":"Tsai","year":"2007","journal-title":"Med Hypotheses"},{"issue":"11","key":"10.1016\/j.mehy.2011.02.027_b0115","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/eji.200737398","article-title":"T cell independent mechanism for copolymer-1-induced neuroprotection","volume":"37","author":"Liu","year":"2007","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2011.02.027_b0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.expneurol.2009.10.015","article-title":"B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis","volume":"221","author":"Kala","year":"2010","journal-title":"Exp Neurol"},{"issue":"1-2","key":"10.1016\/j.mehy.2011.02.027_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.11.016","article-title":"Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis","volume":"219","author":"Begum-Haque","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"8","key":"10.1016\/j.mehy.2011.02.027_b0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/1352458509106230","article-title":"Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?","volume":"15","author":"Bar-Or","year":"2009","journal-title":"Mult Scler"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711000788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711000788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:15:39Z","timestamp":1759691739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711000788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0306987711000788"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.02.027","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2011.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}